Raj Prabhakar
Corporate Officer/Principal chez ROCKET PHARMACEUTICALS, INC.
Fortune : - $ au 31/03/2024
Profil
Raj Prabhakar is currently the Chief Business Officer & Senior Vice President at Rocket Pharmaceuticals, Inc. Prior to his current position, he held the role of Executive Director-Business Development at Imunon, Inc. from 2004 to 2015.
Following that, he served as the Senior Vice President-Business Development at Caladrius Biosciences, Inc. from 2015 to 2017.
Mr. Prabhakar completed his undergraduate studies at Massachusetts Institute of Technology and holds an MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Raj Prabhakar
| Sociétés | Poste | Début |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 |
Anciens postes connus de Raj Prabhakar
| Sociétés | Poste | Fin |
|---|---|---|
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Corporate Officer/Principal | 01/10/2017 |
| IMUNON, INC. | Corporate Officer/Principal | 01/07/2015 |
Formation de Raj Prabhakar
| Massachusetts Institute of Technology | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Caladrius Biosciences, Inc.
Caladrius Biosciences, Inc. BiotechnologyHealth Technology Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes XOWNA, CLBS12, CLBS201 and CLBS14. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. | Health Technology |
